Alkermes Research Development vs Reconciled Depreciation Analysis

ALKS Stock

USD 24.05 0.21 0.87%

Alkermes Plc financial indicator trend analysis is way more than just evaluating Alkermes Plc prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Alkermes Plc is a good investment. Please check the relationship between Alkermes Plc Research Development and its Reconciled Depreciation accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Alkermes Plc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in industry.

For more information on how to buy Alkermes Stock please use our How to Invest in Alkermes Plc guide.

Research Development vs Reconciled Depreciation

Research Development vs Reconciled Depreciation Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Alkermes Plc Research Development account and Reconciled Depreciation. At this time, the significance of the direction appears to have pay attention.

The correlation between Alkermes Plc's Research Development and Reconciled Depreciation is -0.79. Overlapping area represents the amount of variation of Research Development that can explain the historical movement of Reconciled Depreciation in the same time period over historical financial statements of Alkermes Plc, assuming nothing else is changed. The correlation between historical values of Alkermes Plc's Research Development and Reconciled Depreciation is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Research Development of Alkermes Plc are associated (or correlated) with its Reconciled Depreciation. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Reconciled Depreciation has no effect on the direction of Research Development i.e., Alkermes Plc's Research Development and Reconciled Depreciation go up and down completely randomly.

Correlation Coefficient

-0.79

Relationship Direction	Negative
Relationship Strength	Weak

View All Relationships

Research Development

Reconciled Depreciation

Most indicators from Alkermes Plc's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Alkermes Plc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Alkermes Plc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in industry.

For more information on how to buy Alkermes Stock please use our How to Invest in Alkermes Plc guide.At this time, Alkermes Plc's Enterprise Value Over EBITDA is comparatively stable compared to the past year. Enterprise Value Multiple is likely to gain to 9.80 in 2024, despite the fact that Tax Provision is likely to grow to (92.8 M).

	2021	2022	2023	2024 (projected)
Total Operating Expenses	599.1M	1.0B	960.6M	1.0B
Cost Of Revenue	603.9M	218.1M	288.7M	226.3M

Total Operating Expenses Cost Of Revenue

Alkermes Plc fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt	Other Current Liab	Net Receivables	Common Stock Total Equity	Short Term Investments	Common Stock	Current Deferred Revenue
Total Assets		0.55	0.73	0.92	0.66	-0.28	-0.74	0.79	0.79	0.46	0.1	0.84	0.85	0.64	0.43	0.79	0.88	0.65	0.88	-0.06	0.69	0.82	0.88	0.66	0.89	-0.33
Short Long Term Debt Total	0.55		-0.05	0.63	0.72	0.6	-0.08	0.06	0.04	0.96	-0.24	0.28	0.67	0.87	-0.4	0.17	0.33	0.18	0.11	0.24	-0.09	0.07	0.65	0.19	0.68	-0.29
Total Current Liabilities	0.73	-0.05		0.47	0.35	-0.75	-0.95	0.84	0.89	-0.14	0.42	0.65	0.52	0.24	0.76	0.84	0.91	0.81	0.91	-0.3	0.99	0.96	0.61	0.49	0.59	0.12
Total Stockholder Equity	0.92	0.63	0.47		0.61	-0.07	-0.49	0.67	0.6	0.57	-0.17	0.82	0.83	0.56	0.23	0.64	0.63	0.37	0.74	0.05	0.4	0.6	0.83	0.72	0.85	-0.58
Property Plant And Equipment Net	0.66	0.72	0.35	0.61		0.25	-0.59	0.33	0.19	0.77	-0.14	0.38	0.86	0.82	-0.19	0.54	0.58	0.47	0.39	0.0	0.33	0.46	0.81	0.41	0.87	0.07
Net Debt	-0.28	0.6	-0.75	-0.07	0.25		0.59	-0.64	-0.76	0.66	-0.46	-0.45	-0.03	0.31	-0.9	-0.48	-0.48	-0.47	-0.68	0.28	-0.77	-0.69	-0.12	-0.32	-0.06	-0.07
Retained Earnings	-0.74	-0.08	-0.95	-0.49	-0.59	0.59		-0.77	-0.75	-0.05	-0.31	-0.6	-0.66	-0.39	-0.55	-0.87	-0.89	-0.83	-0.85	0.3	-0.95	-0.94	-0.71	-0.51	-0.71	-0.2
Accounts Payable	0.79	0.06	0.84	0.67	0.33	-0.64	-0.77		0.85	0.0	0.27	0.7	0.57	0.19	0.76	0.82	0.78	0.53	0.89	-0.29	0.8	0.88	0.64	0.55	0.62	-0.24
Cash	0.79	0.04	0.89	0.6	0.19	-0.76	-0.75	0.85		-0.09	0.43	0.77	0.49	0.26	0.83	0.72	0.87	0.72	0.93	-0.15	0.88	0.91	0.58	0.49	0.54	-0.18
Non Current Assets Total	0.46	0.96	-0.14	0.57	0.77	0.66	-0.05	0.0	-0.09		-0.22	0.19	0.68	0.85	-0.48	0.1	0.23	0.07	0.0	0.28	-0.17	0.01	0.63	0.15	0.66	-0.29
Non Currrent Assets Other	0.1	-0.24	0.42	-0.17	-0.14	-0.46	-0.31	0.27	0.43	-0.22		-0.07	-0.1	0.05	0.62	0.14	0.41	0.23	0.17	-0.13	0.47	0.38	-0.01	-0.15	-0.06	0.23
Cash And Short Term Investments	0.84	0.28	0.65	0.82	0.38	-0.45	-0.6	0.7	0.77	0.19	-0.07		0.69	0.34	0.47	0.55	0.68	0.54	0.86	0.25	0.6	0.7	0.71	0.75	0.7	-0.38
Common Stock Shares Outstanding	0.85	0.67	0.52	0.83	0.86	-0.03	-0.66	0.57	0.49	0.68	-0.1	0.69		0.76	0.09	0.64	0.69	0.52	0.65	0.06	0.48	0.64	0.98	0.63	0.99	-0.28
Non Current Liabilities Total	0.64	0.87	0.24	0.56	0.82	0.31	-0.39	0.19	0.26	0.85	0.05	0.34	0.76		-0.18	0.34	0.6	0.51	0.29	0.13	0.24	0.33	0.76	0.22	0.77	0.0
Other Current Assets	0.43	-0.4	0.76	0.23	-0.19	-0.9	-0.55	0.76	0.83	-0.48	0.62	0.47	0.09	-0.18		0.52	0.57	0.38	0.71	-0.27	0.76	0.72	0.21	0.36	0.14	-0.06
Other Stockholder Equity	0.79	0.17	0.84	0.64	0.54	-0.48	-0.87	0.82	0.72	0.1	0.14	0.55	0.64	0.34	0.52		0.81	0.67	0.86	-0.6	0.81	0.85	0.7	0.62	0.71	-0.01
Total Liab	0.88	0.33	0.91	0.63	0.58	-0.48	-0.89	0.78	0.87	0.23	0.41	0.68	0.69	0.6	0.57	0.81		0.86	0.86	-0.17	0.9	0.92	0.76	0.45	0.75	0.04
Property Plant And Equipment Gross	0.65	0.18	0.81	0.37	0.47	-0.47	-0.83	0.53	0.72	0.07	0.23	0.54	0.52	0.51	0.38	0.67	0.86		0.72	-0.17	0.83	0.77	0.57	0.25	0.58	0.26
Total Current Assets	0.88	0.11	0.91	0.74	0.39	-0.68	-0.85	0.89	0.93	0.0	0.17	0.86	0.65	0.29	0.71	0.86	0.86	0.72		-0.23	0.88	0.92	0.72	0.72	0.7	-0.18
Short Term Debt	-0.06	0.24	-0.3	0.05	0.0	0.28	0.3	-0.29	-0.15	0.28	-0.13	0.25	0.06	0.13	-0.27	-0.6	-0.17	-0.17	-0.23		-0.31	-0.25	-0.01	-0.13	-0.02	-0.25
Other Current Liab	0.69	-0.09	0.99	0.4	0.33	-0.77	-0.95	0.8	0.88	-0.17	0.47	0.6	0.48	0.24	0.76	0.81	0.9	0.83	0.88	-0.31		0.96	0.57	0.44	0.55	0.18
Net Receivables	0.82	0.07	0.96	0.6	0.46	-0.69	-0.94	0.88	0.91	0.01	0.38	0.7	0.64	0.33	0.72	0.85	0.92	0.77	0.92	-0.25	0.96		0.7	0.51	0.69	-0.02
Common Stock Total Equity	0.88	0.65	0.61	0.83	0.81	-0.12	-0.71	0.64	0.58	0.63	-0.01	0.71	0.98	0.76	0.21	0.7	0.76	0.57	0.72	-0.01	0.57	0.7		0.64	0.99	-0.24
Short Term Investments	0.66	0.19	0.49	0.72	0.41	-0.32	-0.51	0.55	0.49	0.15	-0.15	0.75	0.63	0.22	0.36	0.62	0.45	0.25	0.72	-0.13	0.44	0.51	0.64		0.64	-0.22
Common Stock	0.89	0.68	0.59	0.85	0.87	-0.06	-0.71	0.62	0.54	0.66	-0.06	0.7	0.99	0.77	0.14	0.71	0.75	0.58	0.7	-0.02	0.55	0.69	0.99	0.64		-0.24
Current Deferred Revenue	-0.33	-0.29	0.12	-0.58	0.07	-0.07	-0.2	-0.24	-0.18	-0.29	0.23	-0.38	-0.28	0.0	-0.06	-0.01	0.04	0.26	-0.18	-0.25	0.18	-0.02	-0.24	-0.22	-0.24

Click cells to compare fundamentals

Alkermes Plc Account Relationship Matchups

Alkermes Plc fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	1.8B	1.9B	2.0B	2.0B	2.1B	2.2B
Short Long Term Debt Total	277.1M	275.0M	295.8M	293.3M	290.7M	214.8M
Total Current Liabilities	391.1M	438.3M	471.3M	497.7M	515.7M	541.5M
Total Stockholder Equity	1.1B	1.1B	1.1B	1.0B	1.2B	1.3B
Property Plant And Equipment Net	362.2M	350.0M	341.1M	325.4M	226.9M	162.1M
Net Debt	73.4M	2M	(41.7M)	797K	(166.7M)	(158.4M)
Retained Earnings	(1.4B)	(1.5B)	(1.5B)	(1.7B)	(1.3B)	(1.3B)
Accounts Payable	54.3M	46.0M	55.7M	32.8M	65.6M	68.9M
Cash	203.8M	273.0M	337.5M	292.5M	457.5M	480.3M
Non Current Assets Total	764.0M	814.0M	732.9M	702.1M	705.1M	424.9M
Non Currrent Assets Other	(17.6M)	148.9M	(86.3M)	(1.1M)	157.4M	165.2M
Cash And Short Term Investments	614.4M	659.8M	765.7M	740.1M	813.4M	854.0M
Common Stock Shares Outstanding	157.1M	158.8M	160.9M	163.5M	169.7M	107.2M
Liabilities And Stockholders Equity	1.8B	1.9B	2.0B	2.0B	2.1B	2.2B
Non Current Liabilities Total	328.8M	444.5M	440.6M	422.5M	417.9M	248.1M
Other Current Assets	59.7M	60.7M	49.0M	43.5M	98.2M	103.1M
Other Stockholder Equity	2.5B	2.6B	2.7B	2.8B	2.5B	2.7B
Total Liab	720.0M	882.7M	911.9M	920.2M	933.5M	980.2M
Property Plant And Equipment Gross	362.2M	481.7M	852.2M	874.9M	548.6M	576.0M
Total Current Assets	1.0B	1.1B	1.3B	1.3B	1.4B	1.5B
Accumulated Other Comprehensive Income	(1.8M)	(1.3M)	(3.7M)	(10.9M)	(3.1M)	(3.3M)
Other Current Liab	327.2M	381.9M	406.2M	455.1M	444.3M	466.5M
Net Receivables	265.5M	289.5M	326.6M	296.9M	333.2M	349.8M
Common Stock Total Equity	1.6M	1.6M	1.7M	1.7M	1.9M	1.2M
Short Term Investments	331.2M	362.1M	198.8M	316.0M	316.0M	251.8M
Common Stock	1.6M	1.6M	1.7M	1.7M	1.7M	1.2M
Current Deferred Revenue	6.8M	7.5M	6.3M	6.8M	2.7M	2.6M
Other Liab	49.2M	52.9M	147.8M	42.4M	48.7M	45.4M
Other Assets	140.1M	284.7M	224.9M	122.4M	1.0	0.95
Long Term Debt	274.3M	272.1M	292.8M	290.3M	287.7M	282.4M
Property Plant Equipment	362.2M	350.0M	341.1M	325.4M	374.2M	214.7M
Inventory	101.8M	125.7M	150.3M	181.4M	186.4M	195.7M
Net Tangible Assets	841.9M	862.9M	945.7M	913.2M	1.1B	791.1M
Retained Earnings Total Equity	(1.4B)	(1.5B)	(1.5B)	(1.7B)	(1.5B)	(1.6B)
Long Term Debt Total	274.3M	272.1M	292.8M	290.3M	261.2M	247.6M
Capital Surpluse	2.6B	2.7B	2.8B	2.9B	3.4B	2.5B

Pair Trading with Alkermes Plc

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Alkermes Plc position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alkermes Plc will appreciate offsetting losses from the drop in the long position's value.

Moving together with Alkermes Stock

0.88

JNJ

Johnson Johnson Financial Report 18th of July 2024

Pair Corr

Moving against Alkermes Stock

0.78	MAIA	MAIA Biotechnology	Pair Corr
0.63	NUVB	Nuvation Bio	Pair Corr
0.53	INDP	Indaptus Therapeutics	Pair Corr

The ability to find closely correlated positions to Alkermes Plc could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Alkermes Plc when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Alkermes Plc - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Alkermes Plc to buy it.

The correlation of Alkermes Plc is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Alkermes Plc moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Alkermes Plc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Alkermes Plc can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether Alkermes Plc is a strong investment it is important to analyze Alkermes Plc's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Alkermes Plc's future performance. For an informed investment choice regarding Alkermes Stock, refer to the following important reports:

How To Invest In Alkermes

Details

Is Alkermes Stock a good investment?

Details

What is Alkermes Plc's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Alkermes Plc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in industry.

For more information on how to buy Alkermes Stock please use our How to Invest in Alkermes Plc guide.

You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.

Complementary Tools for Alkermes Stock analysis

When running Alkermes Plc's price analysis, check to measure Alkermes Plc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Alkermes Plc is operating at the current time. Most of Alkermes Plc's value examination focuses on studying past and present price action to predict the probability of Alkermes Plc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Alkermes Plc's price. Additionally, you may evaluate how the addition of Alkermes Plc to your portfolios can decrease your overall portfolio volatility.

	Share Portfolio Track or share privately all of your investments from the convenience of any device
	Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
	Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk
	Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
	Performance Analysis Check effects of mean-variance optimization against your current asset allocation
	Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
	Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
	Bonds Directory Find actively traded corporate debentures issued by US companies
	Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges
	Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity

Is Alkermes Plc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Alkermes Plc. If investors know Alkermes will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Alkermes Plc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

3.36

Revenue Per Share

10.34

Quarterly Revenue Growth

0.218

Return On Assets

0.1465

Return On Equity

0.5045

The market value of Alkermes Plc is measured differently than its book value, which is the value of Alkermes that is recorded on the company's balance sheet. Investors also form their own opinion of Alkermes Plc's value that differs from its market value or its book value, called intrinsic value, which is Alkermes Plc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Alkermes Plc's market value can be influenced by many factors that don't directly affect Alkermes Plc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Alkermes Plc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Alkermes Plc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Alkermes Plc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Alkermes Research Development vs Reconciled Depreciation Analysis

Research Development vs Reconciled Depreciation

Research Development vs Reconciled Depreciation Correlation Analysis

Correlation Coefficient

Research Development

Reconciled Depreciation

Alkermes Plc fundamental ratios Correlations

Alkermes Plc Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Alkermes Plc fundamental ratios Accounts

Pair Trading with Alkermes Plc

Moving together with Alkermes Stock

Moving against Alkermes Stock

Complementary Tools for Alkermes Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Other Current Liab	+ 0.99	Total Current Liabilities
Common Stock	+ 0.99	Common Stock Shares Outstanding
Common Stock	+ 0.99	Common Stock Total Equity
Common Stock Total Equity	+ 0.98	Common Stock Shares Outstanding
Non Current Assets Total	+ 0.96	Short Long Term Debt Total
Net Receivables	+ 0.96	Total Current Liabilities

Other Current Liab	- 0.95	Retained Earnings
Retained Earnings	- 0.95	Total Current Liabilities
Net Receivables	- 0.94	Retained Earnings
Other Current Assets	- 0.9	Net Debt
Total Liab	- 0.89	Retained Earnings
Other Stockholder Equity	- 0.87	Retained Earnings